Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes.

Marwaha AK, Crome SQ, Panagiotopoulos C, Berg KB, Qin H, Ouyang Q, Xu L, Priatel JJ, Levings MK, Tan R.

J Immunol. 2010 Oct 1;185(7):3814-8. doi: 10.4049/jimmunol.1001860. Epub 2010 Sep 1.

2.

IL-17 immunity in human type 1 diabetes.

Honkanen J, Nieminen JK, Gao R, Luopajarvi K, Salo HM, Ilonen J, Knip M, Otonkoski T, Vaarala O.

J Immunol. 2010 Aug 1;185(3):1959-67. doi: 10.4049/jimmunol.1000788. Epub 2010 Jun 30.

3.

Regulatory T cells exert checks and balances on self tolerance and autoimmunity.

Wing K, Sakaguchi S.

Nat Immunol. 2010 Jan;11(1):7-13. doi: 10.1038/ni.1818. Epub 2009 Dec 17. Review.

PMID:
20016504
4.

Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective.

Weaver CT, Hatton RD.

Nat Rev Immunol. 2009 Dec;9(12):883-9. doi: 10.1038/nri2660. Review.

PMID:
19935807
5.

Translational mini-review series on Th17 cells: CD4 T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation.

O'Connor RA, Taams LS, Anderton SM.

Clin Exp Immunol. 2010 Feb;159(2):137-47. doi: 10.1111/j.1365-2249.2009.04040.x. Epub 2009 Nov 11. Review.

6.

How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets.

Feuerer M, Shen Y, Littman DR, Benoist C, Mathis D.

Immunity. 2009 Oct 16;31(4):654-64. doi: 10.1016/j.immuni.2009.08.023. Epub 2009 Oct 8.

7.

Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells.

Bradshaw EM, Raddassi K, Elyaman W, Orban T, Gottlieb PA, Kent SC, Hafler DA.

J Immunol. 2009 Oct 1;183(7):4432-9. doi: 10.4049/jimmunol.0900576. Epub 2009 Sep 11.

8.

The honeymoon phase: intersection of metabolism and immunology.

Aly H, Gottlieb P.

Curr Opin Endocrinol Diabetes Obes. 2009 Aug;16(4):286-92. doi: 10.1097/MED.0b013e32832e0693. Review.

PMID:
19506474
9.

Plasticity of CD4+ T cell lineage differentiation.

Zhou L, Chong MM, Littman DR.

Immunity. 2009 May;30(5):646-55. doi: 10.1016/j.immuni.2009.05.001. Review.

10.

Mechanisms of foxp3+ T regulatory cell-mediated suppression.

Shevach EM.

Immunity. 2009 May;30(5):636-45. doi: 10.1016/j.immuni.2009.04.010. Review.

11.

Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.

Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S.

Immunity. 2009 Jun 19;30(6):899-911. doi: 10.1016/j.immuni.2009.03.019. Epub 2009 May 21.

12.

New definition for the partial remission period in children and adolescents with type 1 diabetes.

Mortensen HB, Hougaard P, Swift P, Hansen L, Holl RW, Hoey H, Bjoerndalen H, de Beaufort C, Chiarelli F, Danne T, Schoenle EJ, Aman J; Hvidoere Study Group on Childhood Diabetes.

Diabetes Care. 2009 Aug;32(8):1384-90. doi: 10.2337/dc08-1987. Epub 2009 May 12.

13.

Human Th17 cells in infection and autoimmunity.

Sallusto F, Lanzavecchia A.

Microbes Infect. 2009 Apr;11(5):620-4. doi: 10.1016/j.micinf.2009.04.004. Epub 2009 Apr 14. Review.

PMID:
19371794
14.

Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

Emamaullee JA, Davis J, Merani S, Toso C, Elliott JF, Thiesen A, Shapiro AM.

Diabetes. 2009 Jun;58(6):1302-11. doi: 10.2337/db08-1113. Epub 2009 Mar 16.

15.

Identification of IL-17-producing FOXP3+ regulatory T cells in humans.

Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu YJ.

Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4793-8. doi: 10.1073/pnas.0900408106. Epub 2009 Mar 9.

16.

IL-17-producing human peripheral regulatory T cells retain suppressive function.

Beriou G, Costantino CM, Ashley CW, Yang L, Kuchroo VK, Baecher-Allan C, Hafler DA.

Blood. 2009 Apr 30;113(18):4240-9. doi: 10.1182/blood-2008-10-183251. Epub 2009 Jan 26.

17.

Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes.

Lawson JM, Tremble J, Dayan C, Beyan H, Leslie RD, Peakman M, Tree TI.

Clin Exp Immunol. 2008 Dec;154(3):353-9. doi: 10.1111/j.1365-2249.2008.03810.x.

18.

The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.

Schneider A, Rieck M, Sanda S, Pihoker C, Greenbaum C, Buckner JH.

J Immunol. 2008 Nov 15;181(10):7350-5.

19.

Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells.

Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, Joosten I.

Blood. 2008 Sep 15;112(6):2340-52. doi: 10.1182/blood-2008-01-133967. Epub 2008 Jul 10.

20.

Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes.

Pfleger C, Kaas A, Hansen L, Alizadeh B, Hougaard P, Holl R, Kolb H, Roep BO, Mortensen HB, Schloot NC; Hvidøre Study Group On Childhood Diabetes.

Clin Immunol. 2008 Jul;128(1):57-65. doi: 10.1016/j.clim.2008.03.458. Epub 2008 Apr 22.

PMID:
18434252
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk